8 European Projects Found
Searched on 125080 European Projects
FINISHED
Neglected Diseases Tres Cantos Open Lab Campus (OPENLABCAMPUS)
Start date: Mar 1, 2013, End date: Feb 28, 2019,
...mpany in the Neglected Diseases Research field as Home (sending) Institution.Scientists funded by the OpenLabCampus Program will access the resources and facilities of the GlaxoSmithKline Tres Cantos Medicines Development Campus in Spain and work alongside its scientists. This programme aims to explore and test innovative open innovation and data sharing approaches which could have a later major i ...
Read Project
1
Partner Participant
FINISHED
IntraVenous ANtibiotic Compounding Automation (IVANCA)
Start date: Mar 1, 2015, End date: Aug 31, 2015,
...f IV antibiotics is very time consuming, especially if conducted in the recommended aseptic conditions. Manual compounding is, however, often conducted in non-aseptic conditions, which exposes the IV medicines to microbial contamination. Contaminated medicines are a serious risk to patients. Hospitals have already begun to adopt automation in care provision. The currently available compounding rob ...
Read Project
1
Partner Participant
FINISHED
Efficient photobioreactor for the production of algae-based chemical resources (LAURA)
Start date: May 1, 2016, End date: Oct 31, 2016,
...of valuable, natural ingredients, specifically targeting the production of i.e. special proteins, omega-3 and omega-6 fatty acids, pigments, anti-oxidants, flavour enhancers, and precursors for medicines. The objective for this Phase 1 feasibility study is to assess an EU roll-out plan and business plan determining for what specific end-products the LAURA platform should be launched for optimal sc ...
Read Project
1
Partner Participant
FINISHED
Join the Europe Experience
Start date: Jun 1, 2016, End date: May 31, 2018,
... healthcare business sector stands for innovative therapies focusing on people. Healthcare consists of the Biopharma, Consumer Health, Allergopharma and Biosimilars businesses. Our prescription medicines – comprising mainly biopharmaceuticals – are used in neurodegenerative diseases, oncology, fertility, endocrinology, cardiometabolic diseases and general medicine. Our consumer health range compri ...
Read Project
10
Partners Participants
FINISHED
Combatting Bacterial Resistance in Europe (COMBACTE-NET)
Start date: Jan 1, 2013, End date: Dec 31, 2019,
... by the US and EU presidencies. The estimated costs of ARB are around € 1.5 Billion per year in Europe, with an estimated 25,000 deaths (European Center for Disease prevention and Control/European Medicines Agency “time to react”). While the threat of antimicrobial resistance is growing, so are the challenges to bringing forward new therapeutic options for patients infected with resistant organis ...
Read Project
38
Partners Participants
FINISHED
Incorporating real-life clinical data into drug development (GETREAL)
Start date: Oct 1, 2013, End date: Dec 31, 2016,
...it is accompanied by an extensive data package that provides information about the safety and efficacy of the medicine in a clinical trial setting. However, assessing the expected future value of the medicines when used in “real world” clinical practice requires additional information next to traditional (pre-authorisation) clinical trials. Regulatory, HTA agencies and other healthcare decision m ...
Read Project
32
Partners Participants
FINISHED
European programme in Pharmacovigilance and Pharmacoepidemiology (EU2P)
Start date: Sep 1, 2009, End date: Jun 30, 2016,
...onomous University of Barcelona, the Erasmus University Medical Center, the University of Utrecht, the University of Hert[ordshire, the University of Verona, the Karolinska Institute and the European Medicines Agency. It will deliver programmes in harmacovigilance and Pharmacoepidemiology for continuing education diploma, Master’s degree as well as PhD and a short course orientated towards risk co ...
Read Project
24
Partners Participants
FINISHED
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)
Start date: Sep 1, 2009, End date: Apr 30, 2015,
...rts and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Agency (EMEA), willdevelop and test methods of proactive monitoring of drug safety and benefit risk (B/R) assessment utilising a large range of EU data sources and expertise. in partnership ...
Read Project
